The invention relates to novel compounds which show highaffinity for cocaine receptors in the brain, particularly dopamineand serotonin transporter sites. The compounds may be used asimaging or pharmaceutical agents, in the diagnosis and treatment ofdrug addiction, depression, anorexia and neurodegenerative diseasesor in determining the doses of therapeutic agents that occupysignificant numbers of receptors.
Cocaine receptor binding ligands
Carroll, F., Kuhar, MJ., Boja, JW., Lewin, A., & Abraham, P. (2004). IPC No. U.S. Cocaine receptor binding ligands. (U.S. Patent No. 6706880).